The amount of cortisol available to its receptors is increased by the pre-receptor enzyme 11b-hydroxysteroid dehydrogenase type 1 (11b-HSD1) which converts cortisone to cortisol. We examined the molecular mechanisms of the feedback effect of cortisol on 11b-HSD1 mRNA expression in human amnion fibroblasts. Our data showed that cortisol-induced 11b-HSD1 mRNA expression dose dependently in amnion fibroblasts, which could be completely blocked both by the mRNA transcription inhibitor 5,6-dichlorobenzimidazole riboside and by the glucocorticoid receptor (GR) antagonist RU486, and partially blocked by global inhibition of CCAAT/enhancerbinding proteins (C/EBPs) with transfection of C/EBP-specific dominant-negative expression CMV500 plasmid (AC/EBP) into the cells. Likewise, the induction of the promoter activity by cortisol could also be completely blocked by RU486 and partially by AC/EBP transfection. Progressive 5 0 deletion of the 11b-HSD1 promoter located the region responsible for cortisol's induction within K204 bp upstream to the transcription start site. Specific nucleotide mutations of the putative glucocorticoid responsive element or CCAAT in this promoter region attenuated the induction by cortisol. Moreover, chromatin immunoprecipitation assay and electrophoretic mobility shift assay showed that GR and C/EBPa but not C/EBPb could bind this promoter region upon cortisol stimulation of amnion fibroblasts. In conclusion, we demonstrated that GR and C/EBPa were involved in cortisol-induced 11b-HSD1 mRNA expression via binding to 11b-HSD1 promoter in amnion fibroblasts, which may cast a feed-forward production of cortisol in the fetal membranes at the end of gestation.
Introduction
The amount of cortisol available to glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) is largely dependent upon the pre-receptor enzyme 11b-hydroxysteroid dehydrogenase (11b-HSD; Seckl 1993 , Draper & Stewart 2005 . There are two isozymes of 11b-HSD in the body (Seckl 1993 , Draper & Stewart 2005 . 11b-HSD1 is ubiquitously distributed in glucocorticoid (GC) target organs where it enhances the binding of cortisol to the relatively low-affinity GR by converting biologically inactive cortisone into active cortisol (Seckl 1993 , Tomlinson et al. 2004 , Draper & Stewart 2005 , while the distribution of 11b-HSD2 is mostly limited to mineralocorticoid target organs where it protects the relatively high-affinity MR from cortisol binding by converting cortisol to cortisone, thus conferring the specific binding of MR by aldosterone (Seckl 1993) .
GCs are important hormones in pregnancy. The placenta, fetal membranes, and the fetus are all GC targets during pregnancy. GCs have been shown to stimulate rather than inhibit prostaglandin and corticotrophin-releasing hormone production in human fetal membranes and placenta (Casey et al. 1985 , Potestio et al. 1988 , Karalis et al. 1996 , King et al. 2002 . These paradoxical effects of GCs on human fetal membranes and placenta are believed to be part of the positive feedback loops involved in human parturition (Whittle et al. 2001) . It is well known that GCs are indispensable hormones for cell differentiation and organ maturation in the fetus (Gonzales et al. 1986 ), but excess of GCs impedes fetal growth (Shams et al. 1998 . In consideration of all these above effects of GCs in pregnancy, understanding the metabolism of GCs by 11b-HSD could undoubtedly have an important impact on the outcome of pregnancy.
Our previous studies have shown that 11b-HSD1 and 11b-HSD2 are differentially distributed in human fetal membranes and placenta, with 11b-HSD1 mainly distributed in the fetal membranes and 11b-HSD2 exclusively distributed in the placenta (Sun et al. 1997a,b) . 11b-HSD2 in the placenta provides a barrier for maternal cortisol entering the fetal circulation . Although the physiological functions of 11b-HSD1 in the fetal membranes are less clear, it is believed that 11b-HSD1 in the fetal membranes may either provide an extra-adrenal source of cortisol for the fetus or simply amplify the local actions of cortisol in the fetal membranes (Murphy 1977 , Alfaidy et al. 2003 .
Human amnion fibroblasts are enriched not only in 11b-HSD1 but also in prostaglandin-synthesizing enzymes . Therefore, it is particularly of interest to examine the regulation of 11b-HSD1 expression in these cells in terms of prostaglandin synthesis. Our previous study has shown that dexamethasone, the synthetic GC, could concurrently increase the expressions of 11b-HSD1 and the key enzymes involved in prostaglandin synthesis such as cytosolic phospholipase A 2 and cyclooxygenase 2 in human amnion fibroblasts . However, the feedback effect of cortisol, the endogenous product of 11b-HSD1-catalyzed reaction, on 11b-HSD1 expression has not been characterized in human amnion fibroblasts.
Sequence analysis revealed a putative GC-response element (GRE) and several consensus CCAAT boxes in human 11b-HSD1 promoter (Tannin et al. 1991) , which may bind either GR or CCAAT/enhancer-binding proteins (C/EBPs) respectively. However, we do not know whether the putative GRE and CCAAT boxes are truly involved in the regulation of 11b-HSD1 expression by GCs. C/EBPs have been reported to be closely related to the actions of GCs in a number of tissues (Rudiger et al. 2002 , Roth et al. 2004 , Yang et al. 2005a ,b, Woltje et al. 2006 . Although C/EBPs have been shown to be involved in basal expression of human or mouse 11b-HSD1 gene transcription (Williams et al. 2000 , Gout et al. 2006 , it is not known whether C/EBPs play any roles in the regulation of 11b-HSD expression by GCs. To address the above issues, we examined the feedback regulation of 11b-HSD1 mRNA expression by cortisol in cultured human amnion fibroblasts and explored the underlying molecular mechanisms.
Materials and Methods

Human amnion fibroblast preparation and treatments
Human fetal membranes were collected from patients undergoing elective cesarean section at term according to the guidelines set forth in a protocol that is in compliance with the Institutional Review Board of Fudan University and University of Cincinnati. Amnion was peeled off chorion and washed thoroughly in cold PBS (pH 7 . 5) to get rid of the residual blood. Amnion was then digested with 0 . 125% trypsin (Sigma) and 0 . 02% DNase (Sigma) twice for 30 min at 37 8C. The digestion media were discarded, and the remaining amnion tissue was washed vigorously with PBS to get rid of residual epithelial cells.
The remaining tissue was then subject to digestion with 0 . 1% collagenase (Roche) at 37 8C for 1 h. The digestion medium was collected and centrifuged at 2300 r.p.m. Cell pellets were resuspended in Dulbecco's modified Eagle's medium (DMEM; Sigma) and loaded onto a discontinuous Percoll (Amersham Biosciences) gradient column (5, 20, 40, and 60%) . The gradient column was centrifuged at 2500 g. and a single band of cells around 20% Percoll concentration was collected. Cells were plated at a density of 1 . 5!10 6 cells per well in a six-well plate in DMEM without phenol red containing 10% fetal calf serum (FCS) and antibiotic-antimycotic solution. The cell identity prepared as described above has been verified previously and more than 90% of the cells are fibroblasts . The amnion fibroblasts were cultured for 2-3 days at 37 8C and 5% CO 2 in air. On the day of treatments, the medium was changed to FCS-free medium and the cells were then treated with cortisol (0 . 01, 0 . 1, and 1 mM) for 24 h with and without the GR antagonist RU486 (1 mM), or in the presence of transfection of C/EBP-specific dominant-negative expression CMV500 plasmid (AC/EBP) or empty CMV500 plasmid (courtesy of Dr Vinson C, National Cancer Institute, Center for Cancer Research, NIH). AC/EBP has been shown to have global inhibition on all C/EBPs (Olive et al. 1996) . The cells were transfected with 0 . 5 mg/well CMV500-AC/EBP or empty CMV500 plasmids using lipofectamine 2000 (Invitrogen) in Opti-MEM (Gibco) 12 h before cortisol treatment. In another set of experiments, the cells were also treated with the mRNA transcription inhibitor 5,6-dichlorobenzimidazole riboside (DRB, 75 mM; Sigma) 1 h prior to cortisol treatment and then DRB treatment was continued with cortisol treatment for another 24 h. At the end of the above treatments, cells were collected for total RNA extraction using RNeasy kit (Qiagen).
RNA (1 . 0 mg) was reverse transcribed with oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers using Superscript II kit (Life Technologies Inc.) for subsequent measurement of 11b-HSD1 mRNA level with real-time PCR (RT-PCR). and power SYBR Green PCR Master Mix (Toyobo, Osaka, Japan). The annealing temperature was set at 61 8C, and amplification cycles were set at 45 cycles. The absolute mRNA levels in each sample were calculated according to a standard curve set up using serial dilutions of known amounts of specific templates against corresponding cycle threshold (C t ) values. Then, the ratio of the target gene over b-actin in each sample was obtained to normalize the expression of the target gene. The specificity of the primers has been verified previously . 0 deletion of the cloned 11b-HSD1 gene promoter was produced with PCR using a combination of a common antisense primer (located immediately before the translation start site) and a series of 5 0 end sense primers (progressing towards the transcription start site) as paired primer sets. The sequences and annealing positions of these primers are shown in Fig. 1 . Restriction sites for KpnI and XhoI are designed into the sense and antisense primers respectively, so that the amplified products carried restriction sites on the 5 0 and 3 0 ends (Fig. 1) . Correspondingly various lengths of 5 0 deleted 11b-HSD1 gene promoters were produced as follows: K1085, K1005, K857, K467, K204, K84, and K64 bp upstream to the transcription start site. All the sub-cloned promoters also carried 93 bp upstream to the translation start site (Fig. 1) . Specific nucleotide mutation was introduced into the predicted sequence responsible for the effect of cortisol by designing the mutation sites into the sense primers (Fig. 1, underlined  nucleotides) . After obtaining the PCR products, the PCR products were cut with KpnI and XhoI and ligated into the polycloning sites of pGL3 enhancer vector upstream to the firefly luciferase reporter gene (Promega). All the above subcloned sequences and mutation sites were verified by examining the size of PCR products upon gel electrophoresis as well as by sequencing.
Measurements
Transient transfection of WISH cells with pGL3 enhancer plasmid carrying 11b-HSD1 promoter-driven luciferase reporter gene and measurement of promoter activity Amnion epithelium-derived WISH cells were obtained from the American Type Culture Collection (Rockville, MD, USA) with the intention of overcoming relatively poor transfection efficiency in primary cells. Passage of WISH cells was carried out with trypsin digestion and the cells were subsequently grown in a 24-well plate in DMEM containing 10% FCS and antibiotic-antimycotic solution and were allowed to grow to about 85-90% confluence at 37 8C and 5% CO 2 in air before the start of transfection and treatments. On the day of transfection, the cells were washed with PBS and the medium was changed to antibiotic-free DMEM containing 10% FCS. Then, the cells were co-transfected with 0 . 5 mg/well of empty pGL3 enhancer plasmid or pGL3 enhancer plasmid carrying 11b-HSD1 promoter-driven firefly luciferase gene and 0 . 05 mg/well of phRL vector carrying renilla luciferase gene using lipofectamine 2000 in Opti-MEM. The phRL vector was used for transfection efficiency control. In another set of experiment, the cells were co-transfected with 0 . 5 mg/well CMV500-AC/EBP plasmid or with 0 . 5 mg/well empty CMV-500 plasmid along with the constructed pGL3 enhancer plasmid. All the above transfection were carried out for 12 h.
After 12 h of transfection, the culture medium was changed to serum-free medium and the cells were treated with cortisol (final concentration: 0 . 001, 0 . 01, 0 . 1, and 1 mM) in the presence and absence of RU486 (1 mM) for 24 h. The culture media were then discarded and the cells were washed with PBS and lysed with lysis buffer (Promega). The cellular debris was pelleted by centrifugation (12 000 g, 1 min at 4 8C).
Figure 1 Illustration of the positions and sequences of primers used for sub-cloning 11b-HSD1 promoter. All the sub-cloned promoters carried KpnI and XhoI sites and were cloned into the corresponding sites upstream to luciferase (Luc) reporter gene of pGL3 enhancer plasmid. Boxed nucleotides are putative glucocorticoidresponse element and C/EBP-binding site and the underlined nucleotides were mutated for both reporter gene study and EMSA study.
The supernatant was used for luciferase activity assay using Dual-Luciferase assay system (Promega) measuring firefly and renilla luciferase of the same samples with a luminometer. The ratio of 11b-HSD1 promoter-driven firefly luciferase activity against renilla luciferase activity was obtained in order to correct differential transfection efficiency in each well and to express the promoter activity.
Demonstration of GR expression in WISH cells with PCR and western blotting analysis
Nuclear protein and total RNA were extracted from some of the WISH cells treated with cortisol (1 mM) overnight using an extraction kit from Active Motif (Carlsbad, CA, USA) and an RNeasy kit from Qiagen respectively. The expression of GR protein was examined following a standard western blotting protocol. Briefly, 50 mg protein of each sample were electrophoresed in 12% Tris-glycine gel (Invitrogen) and transferred to the nitrocellulose blot. The blot was blocked with nonfat milk solution and incubated with 1:1000 dilution of rabbit antibody against GR (Santa Cruz Biotechnology, Santa Cruz, CA, USA) overnight. After washing, the blot was incubated with secondary anti-rabbit IgG antibody conjugated with horseradish peroxidase (Santa Cruz) for 1 h. The enhanced chemiluminescence detection system (Amersham) was used to detect the bands with peroxidase activity. For measurement of GR mRNA level, total RNA was reverse transcribed with oligo(dT) 12-18 primers using Superscript II kit (Life Technologies Inc.) and subsequent standard PCR protocol was followed with the primer sequences as follows: sense 5 0 -GGCAATACCAGGTTTCAGGAACTTACA-3 0 and antisense 5 0 -ATTTCACCATCTACTCTCCCAT-CACTG-3 0 . Reaction solution of PCR consisted of 2 . 0 ml diluted RT-PCR product, and 0 . 2 mM of each paired primers. The annealing temperature was set at 60 8C and amplification cycles were set at 45 cycles. The PCR product was electrophoresed in 1 . 5% agarose gel.
Demonstration of GR and C/EBPa binding to 11b-HSD1 promoter with chromatin immunoprecipitation (ChIP) assay in human amnion fibroblasts Primary human amnion fibroblasts were prepared as described above and plated in 10-cm Petri dishes at a density of 10 7 cells/dish. The cells were treated with cortisol (1 mM) for 12 h before the start of ChIP assay using a kit from Upstate Biotechnology (Temecula, CA, USA) and a method modified from the manufacturer's protocol. Upon termination of treatment, the cells were fixed with 1% formaldehyde to cross-link the transcription factors to chromatin DNA. After washing with PBS, the cells were incubated with glycine (125 mM) for 30 min and then scraped off the dish in cold PBS containing protease inhibitor cocktail. The cells were spun down at 720 g at 4 8C and were resuspended with ice-cold lysis buffer supplemented with protease inhibitor cocktail and incubated on ice for 30 min. The cells were then gently broken up on ice using a Dounce homogenizer to aid nuclei release. The nuclei were spun down at 2400 g, 4 8C and were resuspended in digestion buffer supplemented with protease inhibitor cocktail. Enzymatic shearing of the chromatin DNA was then carried out at 37 8C. The shearing time was optimized according to the pilot study to produce an optimized size of input DNA around 500 bp. The shearing was stopped by adding ice-cold EDTA and the sheared DNA was centrifuged at 2500 g at 4 8C. The supernatant containing sheared DNA was collected for subsequent immunoprecipitation. The diluted sheared DNA was incubated by shaking with GR antibody (Santa Cruz) or C/EBPa antibody (Santa Cruz) or C/EBPb antibody (Santa Cruz) or normal serum as negative control for 12 h at 4 8C. Protein A agarose/salmon sperm DNA was then added to the above solution according to the animal source the antibody was derived from and incubated for 2 h at 4 8C. The antibody/protein/DNA/agarose complex was then spun down at 2500 g and resuspended in low salt buffer and allowed to pass through a filter column (0 . 45 mm).
The column was washed repeatedly with low and high salt buffers, LiCl and TE buffer in order to minimize the nonspecific background. After washing, the filter column was eluted with elution buffer (1% SDS, 0 . 1 M NaHCO 3 ) and the flow through was collected for subsequent reverse cross-linking with 5 M NaCl at 65 8C for 4 h. At the end of reverse cross-linking, 0 . 5 M EDTA, 1 M Tris-HCl (pH 6 . 5), and proteinase K were added and incubated for 1 h at 45 8C. The sheared DNA recovered from reverse cross-linking was extracted with DNA extraction kit for further PCR analysis.
PCR primers for amplifying DNA fragments immunoprecipitated by GR, C/EBPa and C/EBPb antibodies were designed according to the results of 11b-HSD1 promoter analysis study to ensure the primers spanned the predicted promoter region responsible for the regulation by cortisol. The positions and sequences of these primers are illustrated in Fig. 8 . Real-time PCR was performed on the DNA fragments. Some of the PCRs were stopped at 23 cycles and PCR products were analyzed with 2% agarose gel electrophoresis. Some of the PCRs were continued to obtain C t values. The relative level of DNA fragments was calculated according to a standard curve set up using serial dilutions of the PCR product.
Electrophoretic mobility shift assay (EMSA)
In order to further confirm the putative GRE-and C/EBPbinding sites in 11b-HSD1 promoter, EMSA was performed using biotin end-labeled double-stranded oligonucleotides designed according to the 11b-HSD1 promoter-driven reporter gene study. The sense oligonucleotide sequence for putative GRE is as follows: 5 0 -GAATCCAGTCCTGTA-CAGTCATGAGCTT-3 0 , which corresponds to the promoter region from K207 to K178 bp spanning the predicted GRE (underlined). The sense oligonucleotide sequence for putative C/EBP-binding sites is as follows: 5 0 -CCACCCAAAGCCAATCGCTGCTCTGA-3 0 , which corresponds to the promoter region from K86 to K61 bp Z YANG and others . GR and C/EBPa in regulation of 11b-HSD1 spanning the predicted C/EBP-binding site (underlined). To verify the specific binding to the predicted GR and C/EBP sites by the transcription factors, oligonucleotide sequences carrying the same mutations (bold letters) in the predicted GRE and CCAAT as in the reporter gene study were also utilized in the binding reaction. Nuclear protein was extracted from cultured human amnion fibroblasts stimulated by cortisol (1 mM) for 12 h using an extraction kit from Active Motif. The binding reaction of nuclear protein (3 mg) and biotin-labeled oligonucleotides with or without mutations (15 fmol) was carried out overnight at 4 8C in the presence of binding buffer (10 mM Tris, 50 mM KCl, pH 7 . 5), poly (dI . dC; 50 ng/ml) with or without 200-fold molar excess of unlabeled specific competitor sequences or GR antibody (1 mg, Santa Cruz) or C/EBPa antibody (1 mg, Santa Cruz) or C/EBPb antibody (1 mg, Santa Cruz). The binding solution was then electrophoresed in a 6% DNA retardation gel (Invitrogen) in 0 . 5! TBE at 100 V and transferred to a nylon membrane using a semi-dry transfer unit at 380 mA for 30 min. The transferred DNA was cross-linked to the membrane under u.v.-light. The biotin-labeled DNA on the membrane was detected using a LightShift Chemiluminescent EMSA kit (Pierce Biotechnology, Rockford, IL, USA) according to a protocol provided by the manufacturer. Briefly, after blocking, the membrane was incubated with streptavidin-horseradish peroxidase conjugate/blocking buffer. The membrane was then washed and incubated in substrate equilibration buffer. After discarding the substrate equilibration buffer, the membrane was incubated with substrate (luminol/enhancer/stable peroxide solution) for streptavidin-horseradish peroxidase for 1 min and finally the membrane was exposed to X-ray film.
Statistical analyses
All data are reported as meanGS.E.M. Paired Student's t-tests or two-way ANOVA followed by the Student-NewmanKeuls test were used where applicable to assess significant differences between groups. Significance was set at P!0 . 05.
The values for n refer to the number of experiments performed with primary cells prepared from different patients or from different passages of WISH cells.
Results
Induction of 11b-HSD1 mRNA expression by cortisol in human amnion fibroblasts
Treatment of human amnion fibroblasts with cortisol for 24 h caused an average of 3 . 6-and 7 . 9-fold increases in 11b-HSD1 mRNA expression respectively at 0 . 1 and 1 mM, but not at 0 . 01 mM cortisol (Fig. 2) . Treatment of the cells with the mRNA transcription inhibitor DRB (75 mM) completely blocked the induction of 11b-HSD1 mRNA expression by cortisol (0 . 1 mM; Fig. 3, top panel) , suggesting that this induction was dependent on the ongoing transcription.
The induction of 11b-HSD1 mRNA expression by cortisol (0 . 1 mM) could also be completely blocked by the GR antagonist RU486 (1 mM, Fig. 3 , middle panel) and partially blocked by global inhibition of C/EBPs with transfection of AC/EBP into the cells (Fig. 3, bottom panel) .
Basal and cortisol-induced 11b-HSD1 promoter activity in WISH cells transfected with pGL3 enhancer plasmid carrying 11b-HSD1 promoter-driven reporter gene
In order to overcome the relative difficulties in transfecting primary amnion fibroblasts, a human amnion epitheliumderived immortalized cell line, WISH cells, was used for promoter analysis study. Analysis with PCR and western blot revealed GR mRNA and protein expression in WISH cells (Fig. 4, top panel) . All the plasmid constructs containing different lengths of 11b-HSD1 promoter exhibited basal promoter activity when transfected into WISH cells, while the empty pGL3 enhancer plasmid bearing no promoter exhibited mostly background activity (Fig. 4, open columns) . The basal promoter activitywas significantly increased when the 5 0 end of K1085 bp was deleted to K1005 bp and was further dramatically increased when deleted to K857 bp (Fig. 4 open  columns) . There was no further change with deletion from K857 to K467 bp (Fig. 4, open columns) . However, the basal activity was dramatically decreased with deletion from K467 to K204 bp (Fig. 4, open columns) . Further modest decrease was observed with deletion from K204 to K84 bp, but there was no further change with deletion from K84 to K64 bp (Fig. 4 , open columns). These observations suggest that repressors for promoter activity might exist in the promoter region upstream to K857 bp, while enhancers for promoter activity might exist in the promoter region between K857 and K204 bp.
Cortisol (1 mM) treatment of the cells transfected with the above constructed plasmids significantly increased all the promoter activities including K1085, K1005, K857, K467, K204, and K84 bp except the K64 bp promoter (Fig. 4) . Moreover, similar fold of cortisol-induced increases was observed among the promoters of K204, K1005, and K1085 bp, which was significantly greater than the fold of increases induced by cortisol in promoters of K467 and K857 bp (P!0 . 05). These observations suggest that the high basal activity of K467 and K857 bp might impede further increases upon cortisol stimulation. In consideration of the dramatic decrease in cortisol-induced promoter activity with deletion from K204 to K84 bp (Fig. 4) and the similar fold of cortisol-induced increases among the promoters of K204, K1005, and K1085 bp, we inferred that the promoter region downstream to K204 bp and upstream to K84 bp might bear a crucial cortisol-response element, although the involvement of other promoter regions both upstream to K204 bp and downstream to K84 bp in cortisol's induction could not be ruled out. Such an element was shown to be present in the promoter region between K84 and K64 bp, though appeared to be less important, as cortisol caused a modest increase of promoter activity of the K84 bp (Fig. 4) .
Effect of GR antagonist RU486 and co-transfection of AC/EBP plasmid on cortisol-induced 11b-HSD1 promoter activity in WISH cells
Sequence analysis of the promoter region downstream to K204 bp and upstream to K64 bp with transcription element search system (TESS) revealed a putative GRE and several CCAAT boxes in this region. Based on this analysis, we further studied the effect of cortisol in this region in relation to the roles of GR-and CCAAT-binding proteins, C/EBPs. Results showed that cortisol induced the promoter activity of K204 bp in a dose-dependent manner (Fig. 5, top panel) .
Co-treatment of the cells with cortisol (0 . 1 mM) and the GR antagonist RU486 (1 mM) completely blocked the induction of the promoter activity of K204 bp by cortisol (Fig. 5 , bottom panel), suggesting that the induction was fully dependent on GR activation. Despite this, the induction of the promoter activity of K204 bp by cortisol (0 . 1 mM) could also be partially blocked by global inhibition of C/EBPs with co-transfection of AC/EBP plasmid into the cells (Fig. 6, top panel) , suggesting that in addition to the dominant role of GR, C/EBPs might also be involved in the induction of promoter activity by cortisol. However, the involvement of C/EBPs was more likely to be secondary to GR activation as GR antagonist completely blocked the induction by cortisol. Nevertheless, inhibition of C/EBPs with AC/EBP plasmid transfection completely inhibited cortisol (0 . 1 mM)-induced promoter activity of K84 bp (Fig. 6, bottom panel) , suggesting that C/ EBPs, possibly secondary to GR activation, were the transcription factor responsible for cortisol's induction in the region downstream to K84 bp and upstream to K64 bp.
Effect of specific nucleotide mutations in the putative GRE and C/EBP-binding site (CCAAT box) on cortisol-induced 11b-HSD1 promoter activity Based upon the above promoter studies, we introduced nucleotide mutations (underlined and bold letters) into the putative GRE (CTGTACAG) at K197 to K190 bp of the K204 bp promoter and a C/EBP-binding site (CCAAT box, CCAATC) at K76 to K71 bp of the K84 bp promoter (Fig. 1) . Although single nucleotide mutation of the putative GRE at position K192 bp (from C to T) did not affect the induction by cortisol (data not shown), two nucleotide mutations at positions K194 and K193 bp (from TA to CG) partially inhibited the induction of the promoter activity of K204 bp by cortisol (Fig. 7, top panel) , while two nucleotide mutations of the CCAAT box at positions K75 and K73 bp (from C and A to T and G respectively) almost completely blocked the induction of the promoter activity of K84 bp by cortisol (Fig. 7, bottom panel) . These observations further confirmed the involvement of the predicted GRE and CCAAT in cortisol-induced 11b-HSD1 promoter activity on the one hand and also suggested that in addition to GRE, other elements such as CCAATwere also involved in cortisol's induction on the other hand.
Binding of GR and C/EBPa but not C/EBPb to 11b-HSD1 promoter upon cortisol stimulation in human amnion fibroblasts
ChIP assay showed that treatment of human amnion fibroblasts with cortisol (1 mM) for 12 h caused association of GR and C/EBPa to 11b-HSD1 promoter as reflected by the abundance of PCR products amplified using primers spanning the predicted promoter sequences (Fig. 8 , middle panel). Analysis with qRT-PCR also revealed that the amount of DNA precipitated by GR or C/EBPa antibody was more in cortisol stimulation group than that of without cortisol stimulation group (Fig. 8, bottom panel) . However, there were no obvious differences between cortisol and without cortisol-treated groups using DNA precipitated by C/EBPb antibody (data not shown), suggesting that cortisol caused no obvious binding of C/EBPb to 11b-HSD1 promoter. EMSA revealed that nuclear protein extracted from amnion fibroblasts stimulated by cortisol for 12 h could bind the oligonucleotides at positions of K207 to K178 bp spanning the predicted GRE producing distinguishable shifted band upon gel electrophoresis (Fig. 9, upper) . Incubation with GR antibody but not C/EBPa antibody supershifted the band (Fig. 9, upper left) . Although there was some binding of the mutated oligonucleotides bearing the putative GRE with the nuclear protein, incubation of GR antibody caused no obvious supershift of the binding (Fig. 9 , upper right). Likewise, nuclear protein derived from amnion fibroblasts simulated by cortisol could also bind the oligonucleotides spanning the predicted CCAAT box at positions of K86 to K61 bp and produced distinguishable shifted band upon gel electrophoresis (Fig. 9, bottom) . Incubation of the CCAAT oligonucleotides with C/EBPa antibody but not C/EBPb antibody supershifted the band (Fig. 9, bottom left) , while incubation of the mutated oligonucleotides bearing CCAAT with C/EBPa antibody produced no obvious supershifted band (Fig. 9, bottom right) . These observations were consistent with the results of ChIP assay, suggesting C/EBPa rather than C/EBPb was involved in the induction of 11b-HSD1 promoter activity by cortisol. In addition, there were no obvious shifts observed in incubation without nuclear protein (far left lane in each gel picture of Fig. 9 ) and all the shifts and supershifts produced by nuclear protein and antibodies were abolished when excessive nonlabeled-specific oligonucleotides were included in the incubation (far right lane in each gel picture of Fig. 9) , suggesting that the binding of nuclear protein to the oligonucleotides was specific.
Discussion
Previous studies in humans and animals have shown that GCs increase 11b-HSD1 expression in a number of tissues and cells (Hammami & Siiteri 1991 , Bujalska et al. 1997 , Whorwood et al. 2002 , Li et al. 2006 . In this study, we demonstrated that cortisol, the endogenous GC as well as the end product of 11b-HSD-catalyzed reduction reaction, could positively feedback on 11b-HSD1 mRNA expression in human amnion fibroblasts. This feed-forward regulation could be achieved at cortisol concentration around 0 . 1 mM, which may be reached at the end of pregnancy both in maternal plasma and amniotic fluid (Blankstein et al. 1980) . Although 11b-HSD1 is a relatively low-affinity enzyme for the substrate with a K m value in the micromolar range (Seckl 1993 , Tomlinson et al. 2004 , Draper & Stewart 2005 , cortisone, like cortisol, rises steadily with gestational age in the amniotic fluid, and reaches the micromolar range at the end of pregnancy (Blankstein et al. 1980) . In consideration of Z YANG and others . GR and C/EBPa in regulation of 11b-HSD1 these facts, we speculate that the reaction catalyzed by 11b-HSD1 in the fetal membranes could become feed forward at the end of pregnancy. Nevertheless, Alfaidy et al. (2003) also demonstrated that the expression of 11b-HSD1 in the fetal membranes increased with gestational age. This feedforward expression of 11b-HSD1 at the end of gestation may be required both for the full activation of GR in the fetal membranes and for fetal maturation (Murphy 1977) . Cortisol derived from fetal membranes might be supplemental to the function of fetal adrenal glands, as the adrenal glands of the human fetus mainly produce dehydroepiandrosterone rather than cortisol during gestation (Mesiano & Jaffe 1997) . The finding that the homozygous mice with a targeted disruption of 11b-HSD1 gene have impaired surfactant protein production in the lung, lends further support for a crucial role of 11b-HSD1 in fetal maturation (Hundertmark et al. 2002) . Tannin et al. (1991) isolated a human cDNA clone encoding 11b-HSD1 from a human testis cDNA library. Their primer extension analysis using liver RNA indicated that transcription starts 93 bp upstream from the translation start site. Their data also showed that there was no TATA box in the 5 0 untranslated region, but there were a consensus CCAAT box at K76 bp upstream from the start of transcription and a palindromic sequence resembling part of a GRE at K188 bp upstream from the start of transcription. In this study, we found that cortisol induced similar extent of increases in the promoter activities of K204, K1005, and K1085 bp, and the induction was greatly decreased when deletion progressed from K204 to K84 bp and disappeared when deletion progressed to K64 bp. These observations suggested that a crucial GRE might be present in the promoter region between K204 and K84 bp, although other promoter regions could also participate, such as the one in between K84 and K64 bp as demonstrated in this study. Coincidently, the promoter region between K204 and K84 bp contains the putative GRE and the promoter region between K84 and K64 bp contains CCAAT box respectively, as speculated by Tannin et al. (1991) .
GCs act through binding to their cytosolic GR, serving as a transcription factor. Once activated by GCs, GRs forms homodimers and translocate into the nucleus, where they ultimately bind to specific GRE on gene promoters to regulate transcription (Hayashi et al. 2004 , Smoak & Cidlowski 2004 . However, this mechanism dose not explains all the actions of GCs. Several studies demonstrated that interaction of GR with other transcription factors could provide an alternative pathway for GC actions (Hayashi et al. 2004 , Smoak & Cidlowski 2004 . GCs have been found to induce C/EBPa or C/EBPb expression in a number of tissues or cells (Zilberfarb et al. 2001 , Hernandez et al. 2003 , Yang et al. 2005a . Furthermore, interaction of C/EBP a and GR has been found to regulate cell proliferation (Rudiger et al. 2002 , Roth et al. 2004 . Williams et al. (2000) found that C/EBPa was an important regulator of mouse basal 11b-HSD1 promoter activity in hepatoma cells. In a recent study, C/EBPb was also found to regulate human 11b-HSD1 promoter activity in mouse adipose cells (Gout et al. 2006) . All these findings pointed to a role of C/EBPs in the regulation of 11b-HSD1 expression at least at the basal status. In this study, we found that the induction of 11b-HSD1 mRNA expression and promoter activity by cortisol involves not only GR but also C/EBPa.
The observation that the induction of 11b-HSD1 expression could be completely blocked by a GR antagonist suggests a predominant role of GR in this induction. Studies of GRE mutation, ChIP assay, and EMSA not only confirmed the putative GRE in 11b-HSD1 promoter but also provided evidence for a direct interaction of GR with GRE in 11b-HSD1 promoter. However, in addition to the direct interaction of GR with GRE, this study also provided evidence for an indirect role of GR in the induction of 11b-HSD1 promoter activity by cortisol, as the induction of both 11b-HSD1 mRNA expression and promoter activity by cortisol could also be partially blocked by C/EBP inhibition. A number of studies (Zilberfarb et al. 2001, Hernandez et al. 2003, Yang et al. 2005a,b) have demonstrated that GCs induced C/EBP expression in various tissues. These observations were in favor of the participation of C/EBPs in the induction of 11b-HSD1 expression by cortisol. Furthermore, the ChIP assay and EMSA in this study revealed that C/EBPa rather than C/EBPb was involved in the induction by cortisol. This observation was supported by the study of Williams et al. (2000) showing that C/EBPa was a powerful transcription factor for the induction of basal 11b-HSD1 mRNA expression in the mouse, while C/EBPb functioned mainly as a relative inhibitor of basal 11b-HSD1 expression.
However, it should also be kept in mind that there are several CCAAT-like sequences both upstream and downstream to K84 bp as revealed by TESS analysis. Using footprint analysis, Williams et al. (2000) also found multiple C/EBPa-binding sites scattered along the K812 bp of mouse 11b-HSD1 promoter. Thus, in addition to the CCAAT box downstream to K84 bp as demonstrated in this study, other CCAAT-like sequences upstream to K84 bp may also participate in the induction of 11b-HSD1 expression by cortisol.
In conclusion, we demonstrated in this study that the feedforward regulation of 11b-HSD1 gene expression by cortisol involves both direct binding of GR to GRE in the promoter and indirect activation of C/EBPa binding to the CCAAT box in the promoter in human amnion cells. This feedforward regulation of 11b-HSD1 by cortisol may be required for the full local actions of cortisol in the fetal membranes as well as for the fetal maturation at the end of gestation. Z YANG and others . GR and C/EBPa in regulation of 11b-HSD1 Figure 9 Electrophoretic mobility shift assay showing nuclear protein extract from human amnion fibroblasts caused shifts of the oligonucleotides bearing putative glucocorticoid-response element (GRE) or C/EBP-binding site (CCAAT). Glucocorticoid receptor antibody or C/EBPa but not C/EBPb antibody caused supershifts of the respective shifted nuclear protein-oligonucleotide complex. Lane nnp: no nuclear protein; lane no Ab: with nuclear protein but without antibody; lane GR: with nuclear protein and GR antibody; lane C/EBPa: with nuclear protein and C/EBPa antibody; lane C/EBPb: with nuclear protein and C/EBPb antibody; lane NLO: with nuclear protein, antibody and 200-fold nonlabeled oligonucleotides. Wild: oligonucleotide sequence without mutations; mut: oligonucleotide sequence with mutations.
